• Founded in 1997 by Brack Hattler and William Federspiel
  • First human clinical trial performed in November 2009 at Artemis Health Institute, India
  • Pilot Study launched on December 2009 in Germany
  • 7 patents, 2 patent pending
  • Series A fundraising – $14 million October 2010
  • Series B fundraising – $10 million February 2012